A
ARS Pharmaceuticals, Inc. (SPRY)
NGM – Real vaqt narxi. Valyuta: USD
8.54
+0.52 (6.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
8.80
+0.26 (3.04%)
Bozordan keyin: Jun 26, 2026, 7:44 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
8.54
+0.52 (6.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
8.80
+0.26 (3.04%)
Bozordan keyin: Jun 26, 2026, 7:44 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $96.5M naqd pul zahiralaridan ($24.3M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $245.2M jami joriy majburiyatlardan $49.6M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (1.6) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz qoplash koeffitsiyenti (-24.6x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$44.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 4.94 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 4.77 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 1.57 | 0.30 | 4.0 | |
| Qarz/Aktivlar nisbati | 0.34 | 1.04 | 6.0 | |
| Foiz to‘lov qoplami | -24.64 | -16.91 | 1.0 | |
| O‘rtacha ball | 6.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 1M | 30K | 89M | 84M | 99M |
| Yalpi foyda | 997K | -43K | 88M | 64M | 73M |
| Operatsion daromad | -36M | -68M | -3M | -179M | -202M |
| Sof foyda | -35M | -54M | 8M | -171M | -198M |
| EBITDA | -35M | -67M | -3M | -178M | -201M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 108.92 | 0.6 | 6.0 |
| Keyingi chorak | 61.16 | 45.64 | 10 |
| Joriy yil | 72.4 | 4.11 | 7.0 |
| Keyingi yil | 78.04 | 49.66 | 10 |
| O‘rtacha ball | 8.3 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -19.24 | -46.68 | -48.77 | -3.35 | 1.0 |
| Yil/Yil | 184.47 | -78.59 | -74.28 | -10.06 | 3.3 |
| 3 yil o‘rtacha | 98986.72 | -727.92 | -708.81 | -448.05 | 3.3 |
| 5 yil o‘rtacha | 59576.62 | -443.3 | -396.6 | -285.53 | 3.3 |
| O‘rtacha ball | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |